Mahmoud Shehata

2.6k total citations
37 papers, 1.4k citations indexed

About

Mahmoud Shehata is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Mahmoud Shehata has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 15 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Mahmoud Shehata's work include SARS-CoV-2 and COVID-19 Research (14 papers), Influenza Virus Research Studies (14 papers) and Viral gastroenteritis research and epidemiology (8 papers). Mahmoud Shehata is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), Influenza Virus Research Studies (14 papers) and Viral gastroenteritis research and epidemiology (8 papers). Mahmoud Shehata collaborates with scholars based in Egypt, United States and Germany. Mahmoud Shehata's co-authors include Mohamed A. Ali, Ghazi Kayali, Mokhtar R. Gomaa, Ahmed Kandeil, Rabeh El‐Shesheny, Richard J. Webby, Ahmed Mostafa, Yassmin Moatasim, Sara H. Mahmoud and Ahmed E. Kayed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Mahmoud Shehata

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mahmoud Shehata Egypt	18	886	340	332	244	176	37	1.4k
Mokhtar R. Gomaa Egypt	21	970 1.1×	415 1.2×	349 1.1×	224 0.9×	235 1.3×	46	1.5k
Yassmin Moatasim Egypt	25	818 0.9×	558 1.6×	275 0.8×	268 1.1×	389 2.2×	62	1.8k
Ahmed E. Kayed Egypt	14	653 0.7×	423 1.2×	237 0.7×	108 0.4×	284 1.6×	25	1.0k
Rabeh El‐Shesheny Egypt	23	1.1k 1.3×	1.0k 3.0×	342 1.0×	240 1.0×	722 4.1×	81	2.0k
Ahmed Kandeil Egypt	32	1.3k 1.4×	1.0k 3.0×	381 1.1×	461 1.9×	717 4.1×	112	2.7k
Sara H. Mahmoud Egypt	17	334 0.4×	203 0.6×	66 0.2×	280 1.1×	81 0.5×	52	1000
Omnia Kutkat Egypt	19	338 0.4×	162 0.5×	64 0.2×	316 1.3×	73 0.4×	64	1.2k
Ghazi Kayali United States	34	2.1k 2.4×	1.8k 5.4×	735 2.2×	288 1.2×	1.3k 7.4×	120	3.4k
Nongluk Sriwilaijaroen Thailand	20	428 0.5×	852 2.5×	64 0.2×	647 2.7×	249 1.4×	39	2.1k
Jia‐Tsrong Jan Taiwan	25	705 0.8×	745 2.2×	104 0.3×	674 2.8×	101 0.6×	49	1.9k

Countries citing papers authored by Mahmoud Shehata

Since Specialization

Citations

This map shows the geographic impact of Mahmoud Shehata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Shehata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Shehata more than expected).

Fields of papers citing papers by Mahmoud Shehata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud Shehata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Shehata. The network helps show where Mahmoud Shehata may publish in the future.

Co-authorship network of co-authors of Mahmoud Shehata

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud Shehata. A scholar is included among the top collaborators of Mahmoud Shehata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud Shehata. Mahmoud Shehata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahmoud, Sara H., et al.. (2025). In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2. Computational and Structural Biotechnology Journal. 27. 1460–1471. 2 indexed citations

Shehata, Mahmoud, et al.. (2023). Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line. SHILAP Revista de lepidopterología. 14(4). 1687–1701. 2 indexed citations

Shehata, Mahmoud, Walid A. M. Elgaher, Julia Dahlmann, et al.. (2023). NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. PLoS Pathogens. 19(7). e1011506–e1011506. 27 indexed citations

Liu, Lu, Axel Weber, Uwe Linne, et al.. (2023). Phosphorylation of Influenza A Virus Matrix Protein 1 at Threonine 108 Controls Its Multimerization State and Functional Association with the STRIPAK Complex. mBio. 14(1). e0323122–e0323122. 5 indexed citations

Kamel, Mina Nabil, Sara H. Mahmoud, Yassmin Moatasim, et al.. (2022). Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice. Journal of Genetic Engineering and Biotechnology. 20(1). 155–155. 2 indexed citations

Soltane, Raya, Amani Chrouda, Ahmed Mostafa, et al.. (2021). Strong Inhibitory Activity and Action Modes of Synthetic Maslinic Acid Derivative on Highly Pathogenic Coronaviruses: COVID-19 Drug Candidate. Pathogens. 10(5). 623–623. 49 indexed citations

Shehata, Mahmoud, Sara H. Mahmoud, Ahmed A. Al‐Karmalawy, et al.. (2021). In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine. Molecules. 26(20). 6182–6182. 30 indexed citations

Gomaa, Mokhtar R., Amira S. El Refay, Mahmoud Shehata, et al.. (2021). Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathogens. 17(3). e1009413–e1009413. 17 indexed citations

Al‐Karmalawy, Ahmed A., Mai M. Farid, Ahmed Mostafa, et al.. (2021). Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2. Molecules. 26(21). 6559–6559. 65 indexed citations

10.

Al-Wahaibi, Lamya H., Ahmed Mostafa, Yaser A. Mostafa, et al.. (2021). Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease. Bioorganic Chemistry. 116. 105363–105363. 16 indexed citations

11.

Shehata, Mahmoud, et al.. (2021). Improved in vitro Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002. Frontiers in Microbiology. 12. 611958–611958. 13 indexed citations

12.

Mostafa, Ahmed, Ahmed Kandeil, Yaseen A. M. M. Elshaier, et al.. (2020). FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals. 13(12). 443–443. 126 indexed citations

13.

Kandeil, Ahmed, Mokhtar R. Gomaa, Ahmed El Taweel, et al.. (2020). Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS ONE. 15(10). e0241471–e0241471. 11 indexed citations

14.

Gomaa, Mokhtar R., Ahmed Kandeil, Rabeh El‐Shesheny, et al.. (2017). Evidence of infection with avian, human, and swine influenza viruses in pigs in Cairo, Egypt. Archives of Virology. 163(2). 359–364. 23 indexed citations

15.

Kandeil, Ahmed, Yassmin Moatasim, Mokhtar R. Gomaa, et al.. (2015). Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses. Vaccine. 34(2). 218–224. 17 indexed citations

16.

Shehata, Mahmoud, et al.. (2014). Effect of fructooligosaccharides in Cynara scolymus and Allium cepa on carbohydrate and lipid metabolism in rats. 17(1). 3 indexed citations

17.

Chu, Daniel K. W., Leo L. M. Poon, Mokhtar R. Gomaa, et al.. (2014). MERS Coronaviruses in Dromedary Camels, Egypt. Emerging infectious diseases. 20(6). 1049–1053. 228 indexed citations

18.

Kayali, Ghazi, Ahmed Kandeil, Rabeh El‐Shesheny, et al.. (2014). Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012. Emerging infectious diseases. 20(4). 542–551. 73 indexed citations

19.

Kandeil, Ahmed, Rabeh El‐Shesheny, Asmaa M. Maatouq, et al.. (2014). Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013. Archives of Virology. 159(11). 2861–2876. 66 indexed citations

20.

Perera, Ranawaka A. P. M., Peigang Wang, Mokhtar R. Gomaa, et al.. (2013). Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Eurosurveillance. 18(36). pii=20574–pii=20574. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact